In mid-October 2025, the IL Fund announced an additional draw, which was also the final draw of all housing bonds, to be paid on 15 December 2025. The following series of housing bonds have been settled in full: Series 3, 96 IBH36-0115 Series 2, 98 IBH37-1215 Series 2, 98r IBH37-1215r Series 1, 01 IBH26-0315 Series 2, 01 IBH41-0315 On 18 December 2025, the Icelandic parliament Althingi passed legislation repealing the Act on the Processing of Assets and Liabilities of the IL Fund. According to that A ...

Core Viewpoint - Marvion Inc. has entered into a Settlement and Share Issuance Agreement to convert HKD 3,950,000 of debt into equity, enhancing its capital structure and supporting growth initiatives [1][2]. Group 1: Strategic Significance of the Arrangement - The Company will issue 15,816,576 shares at a price of $0.0321 per share, based on the seven-day average closing price prior to the effective date [2]. - Converting liabilities to equity reduces debt obligations, thereby strengthening the Company's capital structure and improving financial flexibility [2][3]. - Settling the liability in shares preserves cash resources for ongoing operations and growth initiatives [3]. Group 2: Stakeholder Alignment and Governance - The equity settlement reflects mutual confidence between Marvion and its creditor, reducing immediate cash outflows [3]. - The arrangement received full approval from the Marvion Board of Directors, indicating strong governance and strategic alignment [3]. Group 3: Outlook and Growth Commitment - Marvion is focused on expanding its integrated logistics, warehousing, and supply chain services across Hong Kong and the Asia Pacific region [4]. - The debt settlement reinforces the Company's capital base, supporting ongoing growth plans and positioning it for enhanced operating momentum and long-term value creation for shareholders [4].

ARLINGTON, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), (“KALA” or the “Company”) today announced the successful completion of its loan settlement with Oxford Finance, LLC (“Oxford”), marking a transformational milestone for the Company. The completion of the settlement resolves critical debt obligations. As previously disclosed in the Company’s Current Report on Form 8-K filed on November 25, 2025, KALA and its subsidiary Combangio, Inc., entered into a Loan Settlement Agreement w ...

Core Insights - A Seattle woman, Mary, faced financial difficulties after co-signing a car loan for a partner, resulting in a remaining balance of approximately $29,000 after a voluntary repossession of a 2019 Volkswagen Jetta [1][3] - Mary earns $61,000 annually, has no savings, and carries $3,000 in credit card debt while still making payments on the vehicle [2] - Financial expert Dave Ramsey emphasized that co-signers become responsible for the loan if the primary borrower defaults, advising Mary to communicate her financial situation to creditors [4][6] Group 1 - Mary co-signed a vehicle loan in fall 2021 for her then-partner, who later failed to make payments, leading to the vehicle's repossession [3] - After the repossession, lenders will pursue the co-signer for any remaining balance once the vehicle is sold at auction, which often results in a deficit [6] - Ramsey advised Mary to inform creditors of her financial situation and suggested that repossession balances can often be settled for less than the full amount owed [7] Group 2 - Mary inquired about placing a lien on her former partner's expected settlement from a motorcycle accident, as she had co-signed for his Harley, which was paid off [4] - Ramsey cautioned against relying on another person's settlement to resolve her debt, indicating that such a strategy is not viable [5]

VANCOUVER, BC / ACCESS Newswire / December 23, 2025 / BeMetals Corp. (TSXV:BMET)(OTCQB:BMTLF)(Frankfurt:1OI.F) (the "Company" or "BeMetals") is pleased to announce that it has reached an agreement to settle C$2,022,814 (US$1,471,351 at an exchange rate of US$1.00 to C$1.3748) in outstanding debt (the "Settlement Amount") held by B2Gold Corp. ("B2Gold") through the issuance of 28,897,343 common shares of the Company ("Common Shares") at a price of C$0.07 per Common Share (the "Debt Settlement"). In connectio ...

Core Viewpoint - Poxel SA is implementing a recovery plan to stabilize its financial situation and avoid liquidation, with new management focused on cost control and business development [3][5][6]. Recovery Plan Update - The recovery plan has been finalized, emphasizing commercial development for Imeglimine, PXL 770, and PXL 065, alongside significant cost reductions and clearing of liabilities [4][5]. - New financing commitments of up to €11.25 million from financial partners IPF and IRIS are aimed at supporting the recovery efforts [5][7]. - The plan requires approval from the Commercial Court of Lyon and will be presented to shareholders at the annual general meeting on December 11, 2025 [5][11]. Financial Structure and Capital Transactions - The recovery plan includes a capital increase with preferential subscription rights for existing shareholders, expected to be at a discount of 30% to 50% of the current share price [12][26]. - A capital increase reserved for IPF will be at a premium of 5% to 10% compared to the preferential subscription rights price [12][26]. - The restructuring aims to ensure that IPF retains approximately 29.9% of the company's share capital post-transaction [17][24]. Management and Strategic Focus - The new management team has been actively working since August to streamline operations and focus on core business areas, including potential partnerships for Imeglimine in Asia [6][9]. - The company plans to reduce administrative costs by transferring its listing to Euronext Growth, which will lower regulatory expenses [10][12]. Shareholder Engagement - A webinar is scheduled for November 26, 2025, to discuss the recovery plan and future prospects with shareholders [5][32]. - Shareholders will have the opportunity to vote on the proposed financial delegations and capital transactions during the upcoming general meeting [11][12].

Core Insights - The article discusses the implications of debt write-offs, particularly in the context of credit card debt and the potential consequences for individuals facing financial hardship [1][3]. Group 1: Debt Write-Off Process - When a credit card company agrees to accept less than the full amount owed, it is termed a debt settlement, where the lender forgives a portion of the debt [4]. - Lenders typically manage these settlements through a hardship or loss-mitigation department, requiring detailed financial disclosures from the debtor [5]. Group 2: Consequences of Debt Settlement - Accepting a debt settlement can negatively impact credit scores, as the lender will report the account as "settled for less than the full balance," which can remain on the credit report for up to seven years [6]. - Forgiven debt may be considered taxable income by the IRS, potentially leading to tax liabilities for the debtor [6]. - Settling a debt usually results in the closure of the credit account, which can adversely affect the credit utilization ratio and overall credit score [6].

Core Viewpoint - Beyond Lithium Inc. has successfully completed the final tranche of its non-brokered private placement, raising a total of $300,000 through the offering, which includes the issuance of units consisting of common shares and warrants [2][8]. Offering Details - The first tranche of the offering was completed on August 28, 2025, raising gross proceeds of $161,323.62, while the final tranche raised $138,676.38 [2][8]. - Each unit issued under the offering consists of one common share and one-half of a common share purchase warrant, with each whole warrant allowing the purchase of one share at $0.10 for 24 months [2][8]. Debt Settlement - The company has also engaged in a debt settlement transaction, issuing 2,800,000 units at a deemed price of $0.03 per unit to settle an outstanding debt of $84,000 in management fees [8]. - A cash commission of $9,013.62 was paid to an eligible third party, representing 7.0% of the proceeds raised from subscribers introduced by this finder [4]. Use of Proceeds - The net proceeds from the final tranche will be allocated for general working capital, exploration activities, expenditures on the Rare One project, and marketing [5]. Regulatory Compliance - The units issued under the offering are not subject to resale restrictions due to the LIFE Exemption, while those issued under the debt settlement are subject to a hold period of four months and one day [6].

Core Points - Mydecine Innovations Group Inc. has successfully closed debt settlement agreements totaling USD $1,386,391 and CAD $9,432,107 to settle outstanding debts with various creditors [1][2] - The company issued five convertible debentures to creditors as part of the debt settlements to preserve cash for working capital and improve its financial situation [2] Debt Settlement Agreements - The company entered into debt forgiveness agreements to settle USD $1,386,391 owed to two former insiders, issuing convertible debentures with an aggregate principal amount of USD $100,000 [4] - A debt settlement agreement with CEO Josh Bartch was made to settle CAD $1,309,836 of unpaid management fees, with a convertible debenture issued for the same amount [5] - A settlement with Pioneer Garage Limited was made for CAD $7,878,792, with a convertible debenture issued under similar terms as the Bartch agreement [6] - An additional settlement with an arm's length creditor for CAD $243,479 was fully settled through a secured convertible debenture of USD $100,000, which bears interest at 1% per month [9] Share Consolidation - The company announced a share consolidation effective October 21, 2025, converting every fifty old common shares into one new common share, reducing the outstanding shares from 61,755,385 to approximately 1,235,107 [12][13] - The share consolidation aims to enhance the company's attractiveness for financing opportunities and facilitate the restructuring of existing liabilities [15]

Core Points - Elixxer Ltd. has settled $5,528,670.19 of debt by issuing 67,014,183 common shares at a price of $0.0825 per share, subject to a four-month hold period and final acceptance by the TSX Venture Exchange [1] - The debt settlement involves related party transactions, with an insider receiving 62,165,699 common shares, and the company is relying on exemptions from certain requirements due to financial difficulties [2] - The board of directors, excluding two members, approved the debt settlement without establishing a special committee or expressing any contrary views [3] Shareholding Changes - Prior to the debt settlement, AIP Convertible Private Debt Fund held 3,633,391 common shares, representing approximately 32.04% of the issued shares on an undiluted basis [4] - After the settlement, AIP's holdings increased to 65,799,090 common shares, representing approximately 83.98% of the issued shares on an undiluted basis [4] Company Overview - Elixxer Ltd. is a Canadian public company listed on the TSX Venture Exchange and the US OTC-Pink exchange, focusing on investments in Canada and other countries, and seeking new high-growth opportunities [5]